DoP to finalise guidelines to select locations of three bulk drug parks and four med devices parks: Gowda Read more
Local API production in India for COVID-19 repurposed drugs may offer competitive advantage: GlobalData Read more
C2 PHARMA opens research access to safety stock of Digoxin API for use in potential COVID-19 combination treatment Read more